Tatiana Pochechueva

发表

Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array

M. Vuskovic, D. Goldstein, R. Caduff, 2012, International journal of cancer.

Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.

N. Bovin, H. Gabius, E. Rapoport, 2008, Glycobiology.

Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients

N. Hacker, N. Bovin, A. Chinarev, 2016, PloS one.

No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting.

D. Goldstein, R. Caduff, V. Heinzelmann-Schwarz, 2011, Gynecologic oncology.

Tumor-Associated Glycans and Their Role in Gynecological Cancers: Accelerating Translational Research by Novel High-Throughput Approaches

A. Fedier, V. Heinzelmann-Schwarz, F. Jacob, 2012, Metabolites.

The glycosphingolipid P1 is an ovarian cancer-associated carbohydrate antigen involved in migration

N. Packer, N. Bovin, A. Fedier, 2014, British Journal of Cancer.

Multiplex suspension array for human anti-carbohydrate antibody profiling.

R. Rieben, E. Korchagina, N. Bovin, 2011, The Analyst.

PEGylation of microbead surfaces reduces unspecific antibody binding in glycan-based suspension array.

N. Bovin, A. Chinarev, A. Fedier, 2014, Journal of immunological methods.

Naturally occurring anti-glycan antibodies binding to Globo H-expressing cells identify ovarian cancer patients

N. Hacker, A. Schötzau, N. Bovin, 2017, Journal of Ovarian Research.

Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies

D. Goldstein, R. Caduff, N. Bovin, 2011, Glycoconjugate Journal.